The Science of SAD: Why Shorter Days Actually Change Brain Chemistry

SAD is sometimes spoken about as if it were a standalone diagnosis, but in the current clinical reference book used in the United States — the DSM-5-TR — it appears slightly differently. The American Psychiatric Association describes it as a specifier called with seasonal pattern, which can be added to major depressive disorder or to bipolar disorder when a person's mood episodes follow a reliable seasonal rhythm. To meet that specifier, the episodes have to show up at the same time of year for at least two consecutive years, with full remission outside that season, and the seasonal episodes have to clearly outnumber any non-seasonal ones over the lifetime.

The most familiar version is fall-onset, winter-pattern SAD, which begins as days shorten and lifts as spring returns. A less common summer-pattern subtype runs in the opposite direction, with symptoms emerging in warmer months. Both are real; the winter form is more often what people mean when they say SAD.

Winter Blues and the Subsyndromal Middle Ground

The phrase winter blues gets used a lot, and not always with much precision. Clinically, what people are usually describing is a milder seasonal mood shift that does not meet the full criteria for a depressive episode. Researchers sometimes call this subsyndromal SAD. The National Institute of Mental Health estimates that around 5 percent of U.S. adults experience full SAD in a given year, with a larger share — often estimated around 10 to 15 percent — experiencing a milder seasonal dip on top of that.

The practical difference between the two is impact. Winter blues might mean a little less energy and a slightly slower start in the mornings, without changing how you function. Clinical SAD interferes with work, relationships, sleep, appetite, or self-care in ways that are hard to push through. Both deserve compassion. Only the second meets the diagnostic threshold for major depression with a seasonal pattern.

SAD does not distribute itself evenly across the population, and the patterns are striking enough to give clues about what is going on underneath.

Geography matters a lot. People living farther from the equator are more likely to develop SAD, presumably because winters bring sharper drops in daylight. One widely cited four-latitude study found prevalence ranging from around 1.4 percent in Florida to around 9.7 percent in New Hampshire, a sevenfold difference within the same country. Women are diagnosed substantially more often than men, with the female-to-male ratio commonly reported at about four to one. Onset tends to fall between the ages of 18 and 30, although it can begin earlier or later. Family history is also a meaningful risk factor — a personal or family background of depression, bipolar disorder, or SAD itself raises the likelihood of developing seasonal mood episodes, with genetic factors thought to account for a meaningful share of the variation in how strongly people respond to seasonal cues.

None of these are guarantees. Plenty of people live far north and feel fine through winter; plenty of people in sunny climates experience SAD anyway. But the gradients are consistent enough to point toward a system that responds to light differently in different bodies, which is exactly what the biology turns out to show.

Here is the part that explains the "actually" in the headline. The link between light and mood is not vague or metaphorical. It runs through a specific set of cells, hormones, and brain regions that have been mapped in real detail. The chain has four meaningful links, and the easiest way to understand SAD is to follow them in order.

The Third Photoreceptor You Have Never Heard Of

When most of us think about how eyes work, we think about rods and cones — the cells that handle vision. For a long time, those were thought to be the whole story. Then, in the late 1990s and early 2000s, researchers identified a third kind of photoreceptor in the human retina: the intrinsically photosensitive retinal ganglion cell, or ipRGC, which uses a pigment called melanopsin to detect light. As described in research summarized by Frontiers in Neurology, ipRGCs are not involved in image formation at all. They have a different job, and arguably an older one. They tell your brain what time of day, and what time of year, it is.

These cells are tuned most strongly to short-wavelength blue light, around 470 to 480 nanometers — the wavelength range that is plentiful in midday outdoor light and noticeably depleted in winter and in most indoor lighting. When the light is bright and blue-rich, ipRGCs fire vigorously and send a clear "daytime" signal deeper into the brain. When the light dims or shifts spectrally, they signal accordingly. In winter, that signal weakens.

How the Signal Reaches the Brain's Master Clock

The destination for those ipRGC signals is a small cluster of neurons in the hypothalamus called the suprachiasmatic nucleus, or SCN. Think of the SCN as a master clock — a tiny conductor coordinating the daily rhythms of nearly every system in your body. It uses the light-versus-dark information coming in from your eyes to synchronize sleep timing, body temperature, hormone release, hunger cues, and a long list of other processes that need to know whether it is morning or night.

One of the SCN's most important downstream messages goes to the pineal gland, which produces melatonin. Melatonin is the hormone that promotes sleep and tells your body it is biological night. In a healthy rhythm, melatonin rises in the evening, peaks during the dark hours, and tapers off before you wake. In winter-pattern SAD, that rhythm shifts. The release tends to start later, last longer into the morning, and overlap more with the part of the day when you are trying to be awake.

The Phase Shift Hypothesis

The most influential explanation for why this shift matters comes from the chronobiologist Alfred Lewy and colleagues at Oregon Health & Science University. Their phase shift hypothesis, summarized in Dialogues in Clinical Neuroscience, proposes that in most people with winter-pattern SAD, the body's circadian clock runs behind the sleep-wake cycle. The internal "biological night" lingers into the social morning. The effect is something like permanent, low-grade jet lag — a chronic mismatch between when your brain thinks it is and when your day actually begins.

What makes this hypothesis particularly persuasive is that Lewy's group tested it directly. They gave low-dose melatonin to people with SAD at different times of day. Afternoon or early-evening doses, which nudge the clock earlier, improved symptoms in the majority of patients. Morning doses, which delay the clock further, made things worse. Placebo doses had little effect. The pattern lines up cleanly with the prediction: correct the misalignment, and mood improves.

The Serotonin Piece

Alongside the circadian story, there is a serotonin story — and the two are connected. Serotonin is a neurotransmitter heavily involved in mood, appetite, and sleep regulation, among many other things. Brain imaging studies, including a positron emission tomography study of the serotonin transporter, suggest that serotonin transporter activity varies with the seasons. In winter, transporter binding tends to be higher, which is consistent with more serotonin being cleared from synapses and less remaining available to do its job. People with SAD appear to show this seasonal pattern more strongly than people without it.

It is worth being careful with this part of the story. The older, simplistic version — "low serotonin causes depression" — has been heavily revised in the research literature. The more accurate framing is that seasonal changes in light appear to drive seasonal changes in serotonin signaling, and people with SAD seem to be more sensitive to those shifts than the general population. It is a piece of the picture, not the whole picture.

Why Some People Feel It More

If the same dark winters happen to everyone, why does SAD affect only some people? Part of the answer seems to live in how the ipRGC system itself functions. Research led by Kathryn Roecklein at the University of Pittsburgh has found that people with SAD tend to show reduced melanopsin-driven retinal responses in winter compared with people without SAD. In other words, their eye-to-brain "daytime signal" may already be a quieter signal, which the dimmer light of winter quiets further. Variation in the melanopsin gene has also been associated with seasonal mood disorder risk.

Layered on top of that retinal variation are the broader risk factors mentioned earlier — sex, age, latitude, and family history — and the kinds of life circumstances that tend to amplify or buffer mood challenges, including sleep schedules, social connection, and stress load. SAD is the meeting point of biology and context, not a single switch that flips.

A Note on Vitamin D

You may have heard that vitamin D causes or cures SAD. The picture is more cautious than that. People with SAD often do have lower vitamin D levels, and vitamin D plays a role in pathways that influence both serotonin and melatonin. Those observational links are interesting. The randomized controlled trial evidence, however, has been less consistent, and federal health resources such as the National Center for Complementary and Integrative Health note that vitamin D supplementation has not been clearly established as effective for SAD. Addressing a documented deficiency may be reasonable for general health reasons, but current evidence does not support vitamin D supplementation as a stand-alone treatment for seasonal mood symptoms.

The winter-pattern profile of SAD looks somewhat different from many people's mental picture of depression. Classical major depression often involves insomnia and a loss of appetite. Winter-pattern SAD, by contrast, often presents with what clinicians call atypical features. The National Institute of Mental Health describes a cluster that typically includes oversleeping, low energy and persistent fatigue, increased appetite — particularly cravings for carbohydrate-rich foods — weight gain, social withdrawal that can feel almost like hibernation, difficulty concentrating, and a persistent low or flat mood, sometimes accompanied by feelings of hopelessness or worthlessness.

The summer-pattern subtype is less common and tends to flip several of these features: insomnia rather than hypersomnia, reduced appetite, weight loss, restlessness, and sometimes agitation or anxiety.

The cluster itself is one of the more recognizable features of SAD. It is not just feeling a bit down on a gray day. It is a whole-body shift in how you sleep, eat, move, and connect, all moving in the same direction at the same time of year.

There is no single right answer for SAD. There are several options with research behind them, each with its own profile, evidence base, and considerations. This section walks through the main ones so that any conversation with a clinician can start from an informed place.

A Quick Comparison

The table below summarizes the most studied options at a glance. It is meant as a starting reference, not a recommendation — each option carries trade-offs that are best worked through individually.

Bright Light Therapy

Bright light therapy is the most extensively studied SAD-specific treatment. The standard protocol, described in American Family Physician, uses a light box that emits around 10,000 lux of white, UV-filtered light. Sessions typically last about 30 minutes in the early morning, with the light positioned roughly 12 to 18 inches from the face, eyes open but not staring directly at the source. Daily use through the symptomatic season is the norm.

Response rates in clinical studies are encouraging, often reported in the range of 60 to 75 percent. In the Can-SAD randomized trial, bright light therapy and the SSRI fluoxetine produced comparable response and remission rates over eight weeks, which puts light therapy squarely in the range of first-line treatment options. Side effects are usually mild — eyestrain, headache, occasional agitation, or trouble falling asleep if the light is used too late in the day. There are some specific groups for whom light therapy may need closer medical oversight, including people with bipolar disorder, certain retinal conditions, or those taking medications that increase light sensitivity. A clinician can help match the device, timing, and duration to a person's situation.

Cognitive Behavioral Therapy for SAD

Cognitive behavioral therapy for SAD, often abbreviated CBT-SAD, is a structured psychotherapy specifically adapted to seasonal depression. Developed by Kelly Rohan and colleagues, the protocol — outlined in a clinical trial overview — typically runs 12 sessions across six weeks, individually or in small groups. Sessions combine two main elements. The first is cognitive work: identifying and gently reshaping the winter-specific thought patterns that tend to deepen the spiral (the "I can't stand winter, there is nothing to do, nothing helps" voice). The second is behavioral activation: deliberately building winter-friendly activities into the calendar so that engagement does not collapse with the temperature.

What makes CBT-SAD especially interesting is what happens after treatment ends. Head-to-head trials suggest that CBT-SAD and bright light therapy produce roughly equivalent benefits during the active treatment period. The difference appears in the years that follow: in long-term follow-up studies, people who received CBT-SAD showed lower recurrence rates over subsequent winters than people who used light therapy alone. The likely reason is that CBT-SAD teaches skills the person carries forward, while light therapy works while it is being used and needs to be restarted each season.

Medications

Two main medication approaches show up in the SAD literature. The first is prevention with bupropion extended-release, which is currently the only medication approved in the U.S. specifically for the prevention of seasonal major depressive episodes. It is typically started in the fall, before symptoms begin, and continued through the symptomatic months. In the pooled pivotal trials summarized by the National Institute of Mental Health, bupropion XL meaningfully reduced the recurrence of winter depressive episodes compared with placebo when started in advance of the symptomatic season.

The second approach is treatment of an active episode with an SSRI such as fluoxetine or sertraline. As mentioned above, the Can-SAD trial found fluoxetine to be roughly as effective as bright light therapy over an eight-week treatment period. As with any medication, the choice, dose, and duration are individualized — a conversation with a clinician who can consider full medical history is the appropriate venue for those decisions.

Lifestyle Adjuncts

The everyday habits that tend to support mood are not magic, and they are not a substitute for treatment in clinical SAD, but the research suggests they can be meaningful adjuncts. Getting outside in the morning, even on cloudy days, exposes the eyes to far more light than typical indoor lighting provides. Keeping consistent sleep and wake times reinforces the same circadian alignment that light therapy targets. Regular aerobic movement has a well-established mood benefit in non-seasonal depression and is reasonable to apply here. Social connection — even modest amounts — can counteract the withdrawal pattern that tends to deepen the seasonal slump.

There is no fixed line between a hard winter and something worth talking to a clinician about, but there are some patterns that tend to be worth taking seriously. Symptoms that recur in the same season for two or more years; symptoms that interfere with work, relationships, parenting, or self-care; growing reliance on alcohol or other substances to manage low mood; and any persistent hopelessness or thoughts of self-harm or suicide all warrant professional support.

If you are in the United States and experiencing thoughts of self-harm or suicide, or are simply in acute distress, the 988 Suicide and Crisis Lifeline is available by call or text, 24 hours a day. It is staffed by trained counselors and can connect you with local resources. Reaching out is not an overreaction; it is one of the more useful things a person can do.

For ongoing care, a primary care clinician is a reasonable first stop. They can rule out other contributors to low energy and mood — thyroid issues, sleep disorders, medication side effects, and similar — and refer to a mental health specialist when that is the right next step.

The reason it is worth understanding the science of SAD is not to turn the experience into a biology lecture, but to make space for a kinder reading of what is happening. If you have spent winter after winter wondering why everyone else seems to push through, the answer is often that your eyes, your master clock, and your serotonin system are interpreting the season slightly differently than theirs are. That difference is not a personal failure, and it is not something anyone has to white-knuckle through alone. There are options, there is a path, and the days, every year, do come back.